Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused

Three patients died in Novartis trials of its CD19-directed CAR-T treatment following a dangerous immune system response, and a similar therapy from Bristol Myers Squibb has also been put on hold to review safety issues ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 1 September →